Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)

The role of metformin (MET) in the treatment of patients with advanced HFrEF and type 2 diabetes mellitus (DM) is not firmly established. We studied the impact of MET on metabolic profile, quality of life (QoL) and survival in these patients. A total of 847 stable patients with advanced HFrEF (57.4 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Benes, Jan, Kotrc, Martin, Kroupova, Katerina, Wohlfahrt, Peter, Kovar, Jan, Franekova, Janka, Hegarova, Marketa, Hoskova, Lenka, Hoskova, Eva, Pelikanova, Terezie, Jarolim, Petr, Kautzner, Josef, Melenovsky, Vojtech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338272/
https://www.ncbi.nlm.nih.gov/pubmed/35906276
http://dx.doi.org/10.1038/s41598-022-17327-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338272/
https://www.ncbi.nlm.nih.gov/pubmed/35906276
http://dx.doi.org/10.1038/s41598-022-17327-4

Ejemplares similares